IDNA Stock: iShares Genomics Immunology and Healthcare ETF Stock Price, Analysis & Insights
Get live IDNA stock price $29.64, comprehensive iShares Genomics Immunology and Healthcare ETF stock analysis, charts, news, and expert forecast. Real-time IDNA stock data and investment insights.
Loading chart data...
iShares Genomics Immunology and Healthcare ETF (IDNA) Overview
iShares Genomics Immunology and Healthcare ETF (IDNA) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, IDNA trades at $29.64 with a market capitalization of 166.66M . Over the past 52 weeks, IDNA has traded between $20.15 and $31.41 , with the current price positioned at approximately 84% of thi...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 166.66M
- Current price: $29.64
- 52-week range: $20.15 - $31.41
- P/E ratio: 19.05
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically ch...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- 50 Hudson Yards
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 19.1)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for iShares Genomics Immunology and Healthcare ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for iShares Genomics Immunology and Healthcare ETF
- ⚠Investors should consider how iShares Genomics Immunology and Healthcare ETF fits within their overall portfolio allocation
Market Cap
166.66M
P/E Ratio (TTM)
19.05
Beta
1.11
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare IDNA with peer companies:
- Price
- $30.36+3.32% (1D)
- Market cap
- 117.48M
- Price
- $69.69+1.02% (1D)
- Market cap
- 142.90M
- Price
- $26.99+2.80% (1D)
- Market cap
- 153.34M
- Price
- $57.50+3.77% (1D)
- Market cap
- 167.97M
- Price
- $41.48+4.40% (1D)
- Market cap
- 136.89M
- Price
- $39.31+3.12% (1D)
- Market cap
- 120.32M
- Price
- $43.76+4.36% (1D)
- Market cap
- 168.38M
- Price
- $22.80+0.22% (1D)
- Market cap
- 121.93M
- Price
- $24.49-0.16% (1D)
- Market cap
- 112.47M
- Price
- $65.38+2.18% (1D)
- Market cap
- 137.66M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
81/100 ⭐⭐⭐⭐⭐
- Overall
- +0.4%
- NYSE
- +0.5%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.4% | +1.9% | +1.9% | 19.6 | 81/100⭐⭐⭐⭐⭐ |
| Healthcare | +1.3% | -1.1% | +2.2% | 30.6 | 72/100⭐⭐⭐⭐⭐ |
| Industrials | +3.1% | -2.1% | +3.7% | 43.2 | 66/100⭐⭐⭐⭐ |
| Technology | +3.3% | -3.9% | +4.1% | 51.3 | 63/100⭐⭐⭐⭐ |
| Communication Services | +0.1% | -1.6% | +1.4% | 22.0 | 61/100⭐⭐⭐⭐ |
| Basic Materials | +1.8% | -2.4% | +0.2% | 27.4 | 52/100⭐⭐⭐ |
| Consumer Defensive | -0.7% | +1.6% | -2.9% | 31.0 | 37/100⭐⭐ |
| Consumer Cyclical | +1.8% | -1.4% | -0.3% | 54.8 | 34/100⭐⭐ |
| Real Estate | -0.2% | -1.1% | -1.2% | 49.5 | 34/100⭐⭐ |
| Energy | -1.6% | -7.5% | +0.2% | 36.1 | 27/100⭐⭐ |
| Utilities | +0.9% | -4.1% | -5.7% | 25.8 | 22/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-11.